North America Swabs collection kit Market

The North America swabs collection kit market is expected to grow from US$ 1,513.73 million in 2021 to US$ 2,087.85 million by 2028. It is estimated to grow at a CAGR of 4.7% from 2021 to 2028.

North America has witnessed a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, as of November 27, 2020, the number of cases increased to 13,248,676, with 269,555 deaths reported in the US. The cases are also increasing in Mexico and Canada. In Mexico, COVID had reached 1,078,594 with 104,242 deaths. Similarly, there were about 353,097 COVID-19 cases in Canada, with 11,799 reported deaths. Samples are taken from places likely to have high virus concentration, i.e., from the back of the nose or mouth or through a bronchoalveolar lavage. Thus, swab collection is a vital step in effectively diagnosing an active infection of the novel coronavirus in the body. The Center for Disease Control and Prevention (CDC) and the US Food and Drug Administration (USFDA) have established standard methods and recommendations for manufacturers to create COVID-19 sample collection and transport kits. With the rising number of hospitals expanding their testing capabilities, the demand for swab collection kits is escalating across North America.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America swabs collection kit market at a good CAGR during the forecast period.

North America swabs collection kit Market Revenue and Forecast to 2028 (US$ Million

)

Get more information on this report Request Free Sample PDF

North America Swabs collection kit Strategic Insights

Strategic insights for the North America Swabs collection kit provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Swabs collection kit Report Scope

North America Swabs collection kit Regional Insights

The geographic scope of the North America Swabs collection kit refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America swabs collection kit Market Segmentation         

The North America swabs collection kit market is analyzed on the basis of type, application, and country. Based on type, the market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the market in 2020. Based on application, the market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the market in 2020. Based on country, the North America swabs collection kit market is segmented into the US, Canada, and Mexico. The US dominated the market in 2020.  

BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Lucence Diagnostics; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc.; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; QIAGEN; and Path-Tec, LLC by Altair are the leading companies in the regional market.